• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
XU Jianpei, XU Qunwei, WANG Xiaoqi, XIN Hongliang. Advances in biomimetic drug delivery systems based on platelet and platelet membrane[J]. Journal of China Pharmaceutical University, 2018, 49(6): 653-659. DOI: 10.11665/j.issn.1000-5048.20180603
Citation: XU Jianpei, XU Qunwei, WANG Xiaoqi, XIN Hongliang. Advances in biomimetic drug delivery systems based on platelet and platelet membrane[J]. Journal of China Pharmaceutical University, 2018, 49(6): 653-659. DOI: 10.11665/j.issn.1000-5048.20180603
shu

Advances in biomimetic drug delivery systems based on platelet and platelet membrane

More Information
    Graphical Abstract
    • Abstract
  • Platelet is an important component of human blood, which plays a key role in the physiological and pathological processes. Recently, novel drug delivery system based on platelet and platelet membrane bionics attracted much attention. Compared to the traditional drug carriers, platelet and platelet membrane-based biomimetic drug delivery system has great performances in biocompatibility, longer circulation and stronger ability of targeting. This review presented the features, classifications, drug-loading and applications of platelet and platelet membrane-based biomimetic drug delivery systems, promoting their development and application in the future.
    • FullText(HTML)
    • References (34)
  • [1]
    Rao L,Bu L,Xu J,et al.Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced acce-lerated blood clearance[J].Small,2016,11(46):6225-6236.
    [2]
    Pelaz B,Charron G,Pfeiffer C,et al.Interfacing engineered nanoparticles with biological systems:anticipating adverse nano-bio interactions[J].Small,2013,9(9/10):1573-1584.
    [3]
    Zhang FR,Wang W.Advances of synthetic lipoproteins as drug nanovectors[J].J China Pharm Univ(中国药科大学学报),2016,47(2):148-157.
    [4]
    Wang YZ,Zhou JP,Ding Y,et al.Advances in research of biomimetic drug delivery systems[J].J China Pharm Univ(中国药科大学学报),2014,43(3):267-273.
    [5]
    López J A,Berliner N.Introduction to a series of reviews on clinical platelet disorders[J].Blood,2017,129(21):2821-2822.
    [6]
    Nurden AT,Nurden P,Sanchez M,et al.Platelets and wound healing[J].Front Biosci,2008,13(13):3532-3548.
    [7]
    Semple JW,Jr IJ,Freedman J.Platelets and the immune continuum[J].Nat Rev Immunol,2011,11(4):264-274.
    [8]
    Cloutier N,Allaeys I,Marcoux G,et al.Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration[J].Proc Natl Acad Sci U S A,2018,115(7):1550-1559.
    [9]
    Münzer P,Borst O,Walker B,et al.Acid sphingomyelinase regulates platelet cell membrane scrambling,secretion,and thrombus formation[J].Arterioscler Thromb Vasc Biol,2014,34(1):61-71.
    [10]
    Jarre A,Gowert NS,Donner L,et al.Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer′s disease[J].Cell Signal,2014,26(9):2040-2050.
    [11]
    Zhao L, Thorsheim CL, Suzuki A, et al. Phosphatidylinositol transfer protein-α in platelets is inconsequential for thrombosis yet is utilized for tumor metastasis[J].Nat Commun,2017,8(1):1216.
    [12]
    Nieswandt B,Watson SP.Platelet-collagen interaction:is GPVI the central receptor[J]?Blood,2003,102(2):449-461.
    [13]
    Wang C,Sun W,Ye Y,et al.In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy[J].Nat Biomed Eng,2017,1(2):0011.
    [14]
    Li J,Sharkey CC,Wun B,et al.Genetic engineering of platelets to neutralize circulating tumor cells[J].J Control Release,2016,228:38-47.
    [15]
    Xu P,Zuo H,Chen B,et al.Doxorubicin-loaded platelets as a smart drug delivery system:an improved therapy for lymphoma[J].Sci Rep,2017,7:42632.
    [16]
    Hu C MJ,Fang RH,Wang KC,et al.Nanoparticle biointerfacing by platelet membrane cloaking[J].Nature,2015,526(7571):118-121.
    [17]
    Lai C,Li C,Luo X,et al.Use of dual-ligand modification in Kupffer cell-targeted liposomes to examine the contribution of Kupffer cells to accelerated blood clearance phenomenon[J].Mol Pharm,2018,15(7):2548-2558.
    [18]
    Hu Q,Sun W,Qian C,et al.Anticancer platelet-mimicking nanovehicles[J].Adv Mater,2016,27(44):7043-7050.
    [19]
    Tesfamariam B.Involvement of platelets in tumor cell metastasis[J].Pharmacol Ther,2016,157:112-119.
    [20]
    Labelle M,Begum S,Hynes RO.Platelets guide the formation of early metastatic niches[J].Proc Natl Acad Sci U S A,2014,111(30):3053-3061.
    [21]
    Li J,Ai Y,Wang L,et al.Targeted drug delivery to circulating tumor cells via platelet membrane-functionalized particles[J].Biomaterials,2016,76:52-65.
    [22]
    Sirotkina OV,Laskovets AB,Goldobin VV,et al.The molecular mechanisms of platelets activation in patients with cerebrovascular disease[J].Biomed Khim,2015,61(5):606-612.
    [23]
    Doshi N,Orje JN,Molins B,et al.Platelet mimetic particles for targeting thrombi in flowing blood[J].Adv Mater,2012,24(28):3864-3869.
    [24]
    Chang ST,Chung CM,Chu CM,et al.Platelet glycoprotein IIb/IIIa inhibitor tirofiban ameliorates cardiac reperfusion injury[J].Int Heart J,2015,56(3):335-340.
    [25]
    Hu Q, Qian C, Sun W, et al. Engineered Nanoplatelets for enhanced treatment of multiple myeloma and thrombus.[J].Adv Mater,2016,28(43):9573-9580.
    [26]
    Erickson PR,Herzberg MC.The Streptococcus sanguis platelet aggregation-associated protein.Identification and characterization of the minimal platelet-interactive domain[J].J Biol Chem,1993,268(3):1646-1649.
    [27]
    Corcoran PA,Atherton JC,Kerrigan SW,et al.The effect of different strains of Helicobacter pylori on platelet aggregation[J].Can J Gastroenterol,2007,21(6):367-370.
    [28]
    Kristinsson SY,Pfeiffer RM,Björkholm M,et al.Thrombosis is associated with inferior survival in multiple myeloma.[J].Haematologica,2012,97(10):1603-1607.
    [29]
    Li J,Angsantikul P,Liu W,et al.Biomimetic platelet-camouflaged nanorobots for binding and isolation of biological threats[J].Adv Mater,2018,30(2).doi: 10.1002/adma.201704800.
    [30]
    Mülfay V,Popa DP.International consensus report on the investigation and management of primary immune thrombocytopenia.[J].Blood,2010,115(2):168-186.
    [31]
    Wei X,Gao J,Fang RH,et al.Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia[J].Biomaterials,2016,111:116-123.
    [32]
    Modery-pawlowski CL,Tian LL,Ravikumar M,et al.In vitro and in vivo hemostatic capabilities of a functionally integrated platelet-mimetic liposomal nanoconstruct.[J].Biomaterials,2013,34(12):3031-3041.
    [33]
    Brown AC,Stabenfeldt SE,Ahn B,et al.Ultrasoft microgels displaying emergent platelet-like behaviours[J].Nat Mater,2014,13(12):1108-1114.
    [34]
    Zhang X,Wang J,Chen Z,et al.Engineering PD-1-presenting platelets for cancer immunotherapy[J].Nano Lett,2018,18(9):5716-5725.
    • Related Articles

  • Related Articles

    [1]ZHAO Xiaomei, WANG Xin, JI Xia, Zhang Jing, ZHANG Hua, HU Guoqiang. Synthesis and antitumor activity of heteroatom-substituted azulenes derivatives of 1,2-benzothiazine[J]. Journal of China Pharmaceutical University, 2024, 55(5): 634-638. DOI: 10.11665/j.issn.1000-5048.2023120503
    [2]SUN Dongyu, GONG Jingxu, LI Xuwen, HAN Guanying, GUO Yuewei. Studies on methyl xestopongoate analogues:design, synthesis and antitumor activities[J]. Journal of China Pharmaceutical University, 2018, 49(4): 413-421. DOI: 10.11665/j.issn.1000-5048.20180405
    [3]LI Mingtao, XU Dan, XUE Wenjun, YOU Qidong, SUN Liping. Design, synthesis and antitumor activities of oxazolo［5, 4-d］pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2017, 48(4): 425-431. DOI: 10.11665/j.issn.1000-5048.20170406
    [4]QIAO Yixue, MOU Yi, HUANG Zhangjian, AI Yong, KANG Fenghua, LAI Yisheng, ZHANG Yihua. Synthesis and antitumor activities of novel CDDO-Me analogues[J]. Journal of China Pharmaceutical University, 2015, 46(3): 289-293. DOI: 10.11665/j.issn.1000-5048.20150305
    [5]MAO Chunfang, XU Chenjun, WANG Xuemin, LI Xianghua, ZHANG Wei, WANG Xinyang, LING Yong. Design, synthesis and antitumor activity of farnesylthiosalicylamide derivatives[J]. Journal of China Pharmaceutical University, 2015, 46(2): 162-168. DOI: 10.11665/j.issn.1000-5048.20150204
    [6]HU Kun, ZHOU Anfei, JIANG Hefei, XU Yuanyuan, HUANG Qianhui, YANG Jie, CHEN Xin, REN Jie. Synthesis and antitumor activities of podophyllotoxin derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 33-38. DOI: 10.11665/j.issn.1000-5048.20140105
    [7]CHENG Keguang, CHU Xiangwu, LIU Guanyan, SU Chunhua, DENG Shengping, PAN Hongmei. Synthesis and antitumor activities of 3-substituted estradiol-pyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2014, 45(1): 26-32. DOI: 10.11665/j.issn.1000-5048.20140104
    [8]LIU Dexiu, PAN Huaying, SHI Hui, HUANG Xiaoying, LOU Hongxiang. Synthesis and antitumor activity of a novel bisbibenzyl derivative[J]. Journal of China Pharmaceutical University, 2013, 44(6): 515-519. DOI: 10.11665/j.issn.1000-5048.20130605
    [9]HU Kun, XU Hua-jin, XIN Wen-qun, CHEN Xin, REN Jie. Synthesis and antitumor activity of nitrogen mustard derivatives of formononetin[J]. Journal of China Pharmaceutical University, 2012, 43(2): 113-119.
    [10]ZHA Xiao-ming, ZHANG Fei-ran, SHAN Jia-qi, CHEN Yan-ke, ZHANG Yi-hua, LIU Jun, SUN Hong-bin. Synthesis and in vitro antitumor activities of novel soladulcidine derivatives[J]. Journal of China Pharmaceutical University, 2010, 41(6): 493-498.

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：366189

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return